Literature DB >> 16625101

Molecular cytogenetic evidence of t(14;18)(IGH;BCL2) in a substantial proportion of primary cutaneous follicle center lymphomas.

Berthold Streubel1, Brigitte Scheucher, Julia Valencak, Daniela Huber, Peter Petzelbauer, Franz Trautinger, Felix Weihsengruber, Christine Mannhalter, Lorenzo Cerroni, Andreas Chott.   

Abstract

In contrast to nodal follicular lymphoma, limited data exist on genetic changes in primary cutaneous follicular lymphoma (primary cutaneous follicle center lymphoma according to WHO-EORTC). The detection rate of the BCL2 rearrangement, representing the characteristic t(14;18)(q32;q21) underlying follicular lymphoma, by polymerase chain reaction (PCR) has been reported to vary over a wide range (0%-41%), and only a few cases have been studied by molecular cytogenetic techniques such as fluorescence in situ hybridization (FISH). In this study, 27 primary cutaneous follicle center lymphomas were analyzed by FISH and the results compared with those obtained by PCR. FISH demonstrated translocations affecting the immunoglobulin heavy chain locus (IGH) in 14 of 27 cases (52%): a t(14;18)(q32;q21) involving BCL2 was found in 11 cases (41%), a t(3;14)(q27;q32) affecting BCL6 in 2 cases (7%), and in 1 case the partner gene of IGH could not be identified. Interestingly, PCR did not detect BCL2 rearrangement in any case. These data suggest that the t(14;18)(q32;q21) frequently occurs in primary cutaneous follicular lymphoma. The reason(s) why BCL2 rearrangements escape the detection by PCR is (are) not clear but could be due to BCL2 mutations, breakpoints outside the amplified DNA, or a high load of somatic mutations.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16625101     DOI: 10.1097/00000478-200604000-00015

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  15 in total

1.  [Malignant lymphoma of the skin: update on diagnostics and therapy of primary cutaneous B-cell lymphoma].

Authors:  C Hallermann; C Niermann; M Fluck; A-R Fischedick; H-J Schulze
Journal:  Hautarzt       Date:  2011-12       Impact factor: 0.751

2.  A case-control study of tobacco use and other non-occupational risk factors for lymphoma subtypes defined by t(14; 18) translocations and bcl-2 expression.

Authors:  Cindy M Chang; Jane C Schroeder; Andrew F Olshan; Cherie H Dunphy; Wen-Yi Huang; Ralph S Baric; Kathleen Conway; James R Cerhan; Charles F Lynch; Nathaniel Rothman; Kenneth P Cantor; Aaron Blair
Journal:  Cancer Causes Control       Date:  2010-03-16       Impact factor: 2.506

3.  Concomitant 1p36 deletion and TNFRSF14 mutations in primary cutaneous follicle center lymphoma frequently expressing high levels of EZH2 protein.

Authors:  Ambrus Gángó; Bence Bátai; Martin Varga; Dóra Kapczár; Gergő Papp; Márta Marschalkó; Enikő Kuroli; Tamás Schneider; Judit Csomor; András Matolcsy; Csaba Bödör; Ágota Szepesi
Journal:  Virchows Arch       Date:  2018-06-01       Impact factor: 4.064

Review 4.  Managing Patients with Cutaneous B-Cell and T-Cell Lymphomas Other Than Mycosis Fungoides.

Authors:  Meenal Kheterpal; Neha Mehta-Shah; Pooja Virmani; Patricia L Myskowski; Alison Moskowitz; Steven M Horwitz
Journal:  Curr Hematol Malig Rep       Date:  2016-06       Impact factor: 3.952

Review 5.  The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications.

Authors:  Elias Campo; Steven H Swerdlow; Nancy L Harris; Stefano Pileri; Harald Stein; Elaine S Jaffe
Journal:  Blood       Date:  2011-02-07       Impact factor: 22.113

6.  Polymerase chain reaction-based clonality analysis of cutaneous B-cell lymphoproliferative processes.

Authors:  Claudia Z Melotti; Maria Fernanda Carriel Amary; Miriam Nacagami Sotto; Timothy Diss; Jose Antonio Sanches
Journal:  Clinics (Sao Paulo)       Date:  2010       Impact factor: 2.365

7.  Follicular lymphoma of the thyroid gland.

Authors:  Chris M Bacon; Timothy C Diss; Hongtao Ye; Hongxiang Liu; Alison Goatly; Rifat Hamoudi; Andrew Wotherspoon; Randy D Gascoyne; Ahmet Dogan; Ming-Qing Du; Peter G Isaacson
Journal:  Am J Surg Pathol       Date:  2009-01       Impact factor: 6.394

8.  Inactivation of p16INK4a/CDKN2A gene may be a diagnostic feature of large B cell lymphoma leg type among cutaneous B cell lymphomas.

Authors:  Marc-Antoine Belaud-Rotureau; Virginie Marietta; Beatrice Vergier; Guillaume Mainhaguiet; Michelle Turmo; Yamina Idrissi; Jacky Ferrer; Marie Beylot-Barry; Pierre Dubus; Jean-Philippe Merlio
Journal:  Virchows Arch       Date:  2008-03-01       Impact factor: 4.064

9.  Low stage follicular lymphoma: biologic and clinical characterization according to nodal or extranodal primary origin.

Authors:  Olga K Weinberg; Lisa Ma; Katie Seo; Andrew H Beck; Reetesh K Pai; Anjali Morales; Youn Kim; Uma Sundram; Daryl Tan; Sandra J Horning; Richard T Hoppe; Yasodha Natkunam; Daniel A Arber
Journal:  Am J Surg Pathol       Date:  2009-04       Impact factor: 6.394

10.  Genomic landscape of cutaneous follicular lymphomas reveals 2 subgroups with clinically predictive molecular features.

Authors:  Xiaolong Alan Zhou; Jingyi Yang; Kimberly G Ringbloom; Maria Estela Martinez-Escala; Kristen E Stevenson; Alexander T Wenzel; Damiano Fantini; Haley K Martin; Andrea P Moy; Elizabeth A Morgan; Shannon Harkins; Christian N Paxton; Bo Hong; Erica F Andersen; Joan Guitart; David M Weinstock; Lorenzo Cerroni; Jaehyuk Choi; Abner Louissaint
Journal:  Blood Adv       Date:  2021-02-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.